Hilland, Geir Haakon
Anthun, Kjartan Sarheim
Funding for this research was provided by:
NTNU Norwegian University of Science and Technology
Article History
Received: 30 March 2023
Accepted: 2 May 2024
First Online: 13 May 2024
Change Date: 4 September 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12889-024-19908-6
Declarations
:
: This study was part of a larger project on ME/CFS in Norway. Approval of individual level health registry data was obtained prior to data collection, by Norway’ Regional Committees for Medical and Health Research Ethics (REK), reference: 2018/293. All methods were performed in accordance with the World Medical Association’ (WMA) Declaration of Helsinki, and it is not possible to identify individual patients from the aggregated data presented in this paper. The need for written informed consent was waived by the Norwegian Medical and Health Research Ethics (REK) ethics committee due to the retrospective nature of the study.
: Not applicable. Data was collected retrospectively from national registries and patient administrative systems, and it was not possible for the authors to directly identify individuals (name, address).
: We have no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.